About
Enhanced Genomics provides a multi-omics platform, GenLink™, that analyzes genome folding to identify genetic drivers of disease and discover genetically validated therapeutic targets, primarily focusing on autoimmune and common diseases.
Explore Enhanced Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.